This website uses cookies
Read our Privacy policy and Terms of use for more information.
Recaps, highlights, and key takeaways from major conferences and events shaping the pharmaceutical and health economics landscape.
NICE
+1
Apr 6, 2026
•
5 min read
A new chief exec, a QALY debate that won't go away, and the moment NICE and the MHRA finally got in the same room.